4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Bonus BioGroup Ltd. (BONS) operates in the Biotechnology industry and is headquartered in Haifa, Israel with about 42 employees. Its market capitalization is roughly ₪227 million. In the fiscal year ended 2025-12-31, BONS reported ₪0M in revenue and (₪24M) in net income.
Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | ₪0M | ₪0M | ₪0M | ₪0M | — |
| Gross Profit | — | (₪2M) | (₪3M) | (₪3M) | (₪4M) |
| Operating Income (EBIT) | (₪24M) | (₪28M) | (₪30M) | (₪37M) | — |
| Net Income | (₪24M) | (₪28M) | (₪28M) | (₪39M) | — |
ILS; ₪M / ₪B as marked. Newest period first. Source: company filings via the Israel Securities Authority’s Magna disclosure system.
| Quarterly income statement | 2024-12-31 |
|---|---|
| Total Revenue | ₪0M |
| Operating Income (EBIT) | (₪6M) |
| Net Income | (₪6M) |
ILS; ₪M / ₪B as marked. Newest period first. Source: company filings via the Israel Securities Authority’s Magna disclosure system.
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | ₪15M | ₪23M | ₪45M | ₪75M | — |
| Total Liabilities | ₪21M | ₪16M | ₪16M | ₪18M | — |
ILS; ₪M / ₪B as marked. Newest period first. Source: company filings via the Israel Securities Authority’s Magna disclosure system.
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BONS viewer.
This page in other languages: עברית
About TickerBase · Data methodology & sources · Privacy · Terms